Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Julphar
McKinsey
Express Scripts
Chinese Patent Office
Argus Health
Queensland Health
Moodys
Merck

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,024,978

« Back to Dashboard

Summary for Patent: 6,024,978
Title: Pharmaceutical compositions comprising cyclosporins
Abstract:Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 -alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
Inventor(s): Hauer; Birgit (Lahr, DE), Meinzer; Armin (Munzingen, DE), Posanski; Ulrich (Freiburg, DE), Richter; Friedrich (Urtenen, CH)
Assignee: Novartis AG (Basel, CH)
Application Number:09/184,546
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 6,024,978

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,024,978

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8821754Sep 16, 1988
United Kingdom8902900Feb 09, 1989
United Kingdom8902903Feb 09, 1989

International Patents Family Members for US Patent 6,024,978

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Hong Kong 86593 ➤ Subscribe
United Kingdom 8821754 ➤ Subscribe
United Kingdom 8902900 ➤ Subscribe
United Kingdom 8902903 ➤ Subscribe
Greece 890100583 ➤ Subscribe
Greece 1000456 ➤ Subscribe
United Kingdom 2222770 ➤ Subscribe
Finland 894342 ➤ Subscribe
Finland 98046 ➤ Subscribe
France 2636534 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Daiichi Sankyo
Colorcon
Dow
Baxter
Cerilliant
McKesson
Medtronic
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot